Business Daily Media

Men's Weekly

.

Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)

  • Written by PR Newswire
Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)

PARIS, March 23, 2021 /PRNewswire/ -- Unither Pharmaceuticals, the Blow-Fill-Seal (BFS) worldwide leader, provides diagnostic companies with capacity solutions and innovative technologies for their testing kits (Covid, Flu, etc.).

Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.) Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)

With more than 10 million unit-doses manufactured each month for Covid testing kits, the French CDMO answers to current challenges based on its sterile unit doses development and manufacturing expertise.

The use of Blow-Fill-Seal technology, enables RNase-free single doses, that can also be sterile if necessary.

Through its 5 BFS plants on three continents (in France, the United States and China) and a R&D development center, Unither is able to manage the full development of a diluent or reagent from formulation to production.

About Unither Pharmaceuticals

Founded in Amiens, France, in 1993, Unither Pharmaceuticals has become a worldwide leader in drug manufacturing for generic pharmaceutical companies including but not limited to, eye drops and respiratory unit doses, saline solutions, and stick-packs.  

Unither Pharmaceuticals has 7 manufacturing sites and 1 R&D center located in France, the United States, China and Brazil. These sites generated a revenue of €330 million in 2020 with a headcount exceeding 1.600 employees.

Website : www.unither-pharma.com[1]

Blow-Fill-Seal : https://www.unither-pharma.com/technologies-innovations/blow-fill-seal-bfs/?lang=en[2]

Article : https://www.unither-pharma.com/news/diluent-or-immuno-reagent-solutions-for-your-diagnostic-testing-kits-covid-flu-etc/?lang=en[3]

Contact: testing@unither-pharma.com[4]  

Photo - https://mma.prnasia.com/media2/1471718/diluent_or_immuno_reagent_solutions.jpg?p=medium600[5] Logo - https://mma.prnasia.com/media2/1471719/Unither_Pharmaceuticals_Logo.jpg?p=medium600[6]

Read more https://www.prnasia.com/story/archive/3317776_AE17776_0

Brisbane’s brightest recognised: Daniel Mikus and James Rolph win Specialist Services Award at the 2025 Brisbane Young Entrepreneur Awards - again

Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...

Members greenlight merger of Regional Australia Bank and Summerland Bank

Regional Australia Bank and Summerland Bank will proceed with a merger after members approved the move at their Annual General Meetings this week...

DesignStreet marks 27 years with a bold rebrand

In a fast-moving industry defined by continuous disruption, one independent creative agency is proving that longevity and innovation can go hand i...

Deputy partners with SuperAPI to streamline employee onboarding and help get shift-based industries ready for PayDay Super

Deputy, the global people platform for shift-based work, has announced a new partnership with SuperAPI, marking a major enhancement to its HR pro...

KuCoin invests in Australian sponsorships of the ACC, plus a major campaign with golf icon Adam Scott

KuCoin, a leading global crypto platform built on trust, announced the appointment of James Pinch as the Australian Managing Director, the establish...

Australian companies pitching to the world’s wealthiest investors

#CapTech 2025 to bring world investors to Australia’s doorstep  One of Australia’s leading business and capital events is bringing together inves...